2023
DOI: 10.1016/j.jvsv.2022.10.008
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and safety of foam sclerotherapy with sodium tetradecyl sulfate as preferred sclerosant of venous malformations based on experience from a single specialist center

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“… 30 Moreover, compared with other regions, pelvic and genital lesions showed a lower reduction in volume after therapy, which may be attributed to the deeper location of pelvic lesions and the reported need for multiple sclerotherapy treatments to achieve remission. 14 It is important to note that the small sample size of lesions at these sites may have introduced bias. The Puig classification of the VMs showed no significant influence on the clinical efficacy, which is consistent with findings in a previous report.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… 30 Moreover, compared with other regions, pelvic and genital lesions showed a lower reduction in volume after therapy, which may be attributed to the deeper location of pelvic lesions and the reported need for multiple sclerotherapy treatments to achieve remission. 14 It is important to note that the small sample size of lesions at these sites may have introduced bias. The Puig classification of the VMs showed no significant influence on the clinical efficacy, which is consistent with findings in a previous report.…”
Section: Discussionmentioning
confidence: 99%
“…11,12 Currently, there is no consensus on the ideal sclerosing agent, with common agents including absolute ethanol, polidocanol foam, bleomycin, and foam sodium tetradecyl sulfate (STS). [13][14][15][16] While anhydrous ethanol has been considered the most effective sclerosing agent for reducing VMs volume, its use is associated with serious complications, such as bleeding and ulcers. 12 Recently, bleomycin polidocanol foam (BPF) has gained widespread acceptance in the treatment of VMs.…”
Section: Introductionmentioning
confidence: 99%